An experimental drug can prevent intestinal damage caused by celiac disease, an early trial has found—raising hopes that it could become the first medication for the serious digestive disorder. With...

A repurposed arthritis drug has shown positive results in a clinical trial of patients hospitalized with COVID-19, according to a paper published Wednesday in the New England Journal of Medicine. Tofacitinib,...

McMaster University researchers have established in lab settings that a novel combination of two forms of immunotherapy can be highly effective for treating lung cancer, which causes more deaths than...

In a proof-of-concept study, North Carolina State University researchers reported promising preclinical findings for a prototype of a vascular graft designed as a replacement for a damaged or blocked...

Scientists identify 21 drugs that show promise for treating COVID-19 – including four that might be used with remdesivir to combat the virus Researchers at Sanford Burnham Prebys Medical Discovery...

In the cover article of the June 11 issue of the Journal of Medicinal Chemistry, a team of researchers at the Medical University of South Carolina, led by Sherine Chan, Ph.D., and James Chou, Ph.D., reports...

Experimental coronavirus vaccine from Pfizer triggered levels of antibodies up to THREE TIMES greater than those seen in recovered patients, early data shows Researchers randomly gave 45 healthy volunteers either...

There’s new evidence that a 2,000-year-old medicine might offer hope against a modern scourge: COVID-19. The medication, called colchicine, is an anti-inflammatory taken as a pill. It’s long...

A new study from Lawson Health Research Institute and Western University suggests that fecal transplants could be used as a treatment for non-alcoholic fatty liver disease (NAFLD). The randomized controlled...

A test that can detect the presence of antibodies to the SARS-CoV-2 virus in the blood of human patients is described in Nature Medicine. This assay, tested in 16 patients, may help to identify individuals...